CIK: 0000924223
Total reported value
$4.0B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CELG | Celgene CORP | Stock-Other | 18.12% | +0.49% | — | |
| 2 | ✓ | Isis Pharmaceuticals INC | Stock-Other | 15.04% | — | — | |
| 3 | GILD | Gilead Sciences INC | Stock-Healthcare | 13.67% | -0.80% | — | |
| 4 | INCY | Incyte CORP | Stock-Healthcare | 8.49% | +0.07% | — | |
| 5 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 8.10% | -1.27% | — | |
| 6 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 5.17% | +0.37% | — | |
| 7 | MODV | ModivCare Inc. | Stock-Other | 5.14% | — | — | |
| 8 | ✓ | Ariad Pharmaceuticals INC | Stock-Other | 3.93% | — | — | |
| 9 | IMGNEUR | Immunogen INC | Stock-Other | 3.90% | — | — | |
| 10 | ✓ | Onyx Pharmaceuticals INC | Stock-Other | 3.42% | — | — | |
| 11 | HALO | Halozyme Therapeutics INC | Stock-Healthcare | 3.23% | -0.53% | — | |
| 12 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 2.47% | — | — | |
| 13 | ✓ | Endocyte INC | Stock-Other | 2.21% | — | — | |
| 14 | ✓ | Optimer Pharmaceuticals INC | Stock-Other | 1.51% | — | — | |
| 15 | INFIQ | Infinity Pharmaceuticals INC | Stock-Other | 1.27% | — | — | |
| 16 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.02% | +0.16% | — | |
| 17 | ACHNEUR | Achillion Pharmaceuticals | Stock-Other | 0.99% | — | — | |
| 18 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 0.71% | — | — | |
| 19 | MDCOUSD | Medicines Company | Stock-Other | 0.67% | — | — | |
| 20 | ✓ | Idenix Pharmaceuticals INC | Stock-Other | 0.33% | — | — | |
| 21 | ✓ | Dendreon CORP | Stock-Other | 0.30% | — | — | |
| 22 | ✓ | Trius Therapeutics INC | Stock-Other | 0.16% | — | — | |
| 23 | ✓ | Synageva Biopharma CORP | Stock-Other | 0.16% | — | — |